|
ZNF623 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.62700000000094E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.159500E-04 |
| Normal-vs-Stage2 |
5.479400E-03 |
| Normal-vs-Stage3 |
8.0630000000026E-05 |
| Normal-vs-Stage4 |
1.195480E-03 |
| Stage1-vs-Stage2 |
6.918600E-01 |
| Stage1-vs-Stage3 |
2.483000E-01 |
| Stage1-vs-Stage4 |
4.587000E-01 |
| Stage2-vs-Stage3 |
6.726600E-01 |
| Stage2-vs-Stage4 |
7.922400E-01 |
| Stage3-vs-Stage4 |
9.007800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.564500E-04 |
| Normal-vs-AfricanAmerican |
5.779600E-02 |
| Normal-vs-Asian |
3.982200E-03 |
| Caucasian-vs-AfricanAmerican |
6.857600E-01 |
| Caucasian-vs-Asian |
8.301400E-01 |
| AfricanAmerican-vs-Asian |
5.984800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.77180000000044E-05 |
| Normal-vs-Female |
3.418400E-04 |
| Male-vs-Female |
3.393200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.581200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.233850E-04 |
| Normal-vs-Age(61-80Yrs) |
2.613000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.699930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.048800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.711400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.510400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.875200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.700200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.247400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.056960E-01 |
| Classical-VS-Follicular |
1.276160E-03 |
| Classical-VS-Other |
2.414000E-01 |
| Classical-VS-Normal |
4.179900E-03 |
| Tall-VS-Follicular |
6.497000E-01 |
| Tall-VS-Other |
7.214200E-01 |
| Tall-VS-Normal |
1.464190E-03 |
| Follicular-VS-Other |
9.204600E-01 |
| Follicular-VS-Normal |
3.91379999997721E-06 |
| Other-VS-Normal |
4.244300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.582940E-04 |
| Normal-vs-N1 |
3.226300E-04 |
| N0-vs-N1 |
3.979800E-01 |
|
|
